• Home >
  • Publications >
  • A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors

1 Jun 2021Nature Cancer

DOI : 10.1038/s43018-021-00203-x

Authors

Jia Zhou, Camille Gelot, Constantia Pantelidou, Adam Li, Hatice Yücel, Rachel E. Davis, Anniina Färkkilä, Bose Kochupurakkal, Aleem Syed, Geoffrey I. Shapiro, John A. Tainer, Brian S. J. Blagg, Raphael Ceccaldi, Alan D. D’Andrea

Members

RAPHAEL CECCALDI

Chargé de recherche Inserm